Abstract:Esophageal inflammation or ulceration is a well recognized side-effect of some oral medications, especially nonsteroidal anti-inflammatory or potassium chloride tablets. A similar injury can be induced by iron but endoscopically detected lesions are rarely reported 1 2. An 82-year-old woman presented a sudden complaint of dysphagia after ingestion of a ferrous sulphate tablet. She had chronic esophageal reflux and Raynaud’s syndrome. Her physical examination was normal. An upper endoscopy revealed a black-brown, ulcerated and necrotic lesion, just below the upper esophageal sphincter, 2 cm in length, well circumscribed and associated with a slight stenosis. Below the lesion the esophageal lumen was distended and atonic, with candidiasis and a grade D peptic esophagitis (Fig. 1, Video 1). Fig. 1 Upper endoscopy at day 1 revealed a black-brown, ulcerated and necrotic lesion, just below the upper esophageal sphincter. Video 1 Upper endoscopy at day 1 revealed a black-brown, ulcerated and necrotic lesion, just below the upper esophageal sphincter and a distended atonic esophagus. Histological evaluation revealed ulcerated esophagitis, with acute inflammatory granulation tissue containing abundant brown crystalline nonbirefringent material, confirmed as iron by Perl’s staining (Fig. 2, 3). Other stainings for brown pigments and infections were negative. Fig. 2 Granulation tissue from the area with ulcerated esophagitis containing abundant brown crystalline material (hematoxylin and eosin, × 400). Fig. 3 Positive blue staining of the crystalline material with Perl’s iron stain (× 400). The patient’s iron tablets were stopped and a high dose proton pump inhibitor was prescribed. The dysphagia was relieved and a repeat upper endoscopy revealed progressive resolution of the necrosis and stenosis (Fig. 4, Video 2). Fig. 4 Upper endoscopy at day 8 showing the progressive resolution of the lesion, with a brown pigmentation and no necrosis. Video 2 Upper endoscopy at day 8 showing the progressive resolution of the lesion with a circumferential brown-pigmented lesion with no necrosis or stenosis. Iron-induced esophageal erosions or ulcerations are seldom described and the differential diagnoses might be striking. Tablet debris seen at endoscopy is diagnostic but rarely detected. Histological examination reveals a typical brown crystalline material positive with Perl’s staining 1 3 4. The pathogenesis is believed to be a high local iron saturation causing a concentration-dependent absorption, resulting in the formation of reactive oxygen metabolites and mucosal injury 3. Anatomical factors such as motility disorders or previous inflammation might predispose to the iron injury 3 4. Treatment requires stopping the offending drug or, if iron is still necessary, changing to a liquid preparation 3 5. Iron-induced lesions are not endoscopically specific and histological investigation is essential to the diagnosis. Endoscopy_UCTN_Code_CCL_1AB_2AC_3AZ

Edoxaban-induced oesophagitis

Safety of edoxaban for delayed bleeding in gastrointestinal endoscopic procedures with a high risk of bleeding

Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature

Dabigatran-induced Esophagitis: A Case Report.

Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant users

Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection

Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management

Potential of Direct Oral Anticoagulant in Bleeding After Gastric Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation

Haemorrhagic exfoliative oesophagitis associated with nasogastric tube placement

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

Edoxaban, Rivaroxaban or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2

Esophageal Damage Following Left Atrial Ablation in a Patient on Dabigatran: Adding Insult to Injury

The Management of Direct Oral Anticoagulants for Colorectal Endoscopic Submucosal Dissection: A Multicenter Observational Study

Timing of Direct Oral Anticoagulants Resumption Following Colorectal Endoscopic Submucosal Dissection: A Nationwide Study in Japan

Rivaroxaban-related acute kidney injury in a patient with IgA vasculitis

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy

Clinical outcomes of edoxaban treatment without parenteral anticoagulation therapy for acute venous thromboembolism: Insight from the COMMAND VTE Registry-2

Direct oral anticoagulant-associated bleeding complications in patients with gastrointestinal cancer and venous thromboembolism

Iron-induced esophageal ulceration

Delayed Vesicular Urticarial Dermatosis Due to Apixaban